The UPS in diabetes and obesity

Prentice AM: The emerging epidemic of obesity in developing countries. Int J Epidemiol. 2006, 35: 93-99. 10.1093/ije/dyi272. Zimmet P, Alberti KG, Shaw J: Global and societal implications of the diabetes epidemic. Nature. 2001, 414: 782-787. 10.1038/414782a. Satoh S, Nishimura H, Clark AE, Kozka IJ, Vannucci SJ, Simpson IA, Quon MJ, Cushman SW, Holman GD: Use of bismannose photolabel to elucidate insulin-regulated GLUT4 subcellular trafficking kinetics in rat adipose cells. Evidence that exocytosis is a critical site of hormone action. J Biol Chem. 1993, 268: 17820-17829. James DE, Strube M, Mueckler M: Molecular cloning and characterization of an insulin-regulatable glucose transporter. Nature. 1989, 338: 83-87. 10.1038/338083a0. Buse JB, Polonsky KS, Burant CF: Type 2 Diabetes Mellitus. Williams Textbook of Endocrinology. Edited by: Larsen PR, Kronenberg HM, Melmed S, Polonsky KS. 2003, Philadelphia: Saunders, 10 Frayn KN, Arner P, Yki-Jarvinen H: Fatty acid metabolism in adipose tissue, muscle and liver in health and disease. Essays Biochem. 2006, 42: 89-103. 10.1042/bse0420089. Liu Z, Long W, Fryburg DA, Barrett EJ: The regulation of body and skeletal muscle protein metabolism by hormones and amino acids. J Nutr. 2006, 136: 212S-217S. Saltiel AR, Kahn CR: Insulin signalling and the regulation of glucose and lipid metabolism. Nature. 2001, 414: 799-806. 10.1038/414799a. Association AD: Diagnosis and classification of diabetes mellitus. Diabetes Care. 2006, 29 (Suppl 1): S43-48. Trujillo ME, Scherer PE: Adipose tissue-derived factors: impact on health and disease. Endocr Rev. 2006, 27: 762-778. Krook A, Brueton L, O'Rahilly S: Homozygous nonsense mutation in the insulin receptor gene in infant with leprechaunism. Lancet. 1993, 342: 277-278. 10.1016/0140-6736(93)91820-C. Ballinger SW, Shoffner JM, Hedaya EV, Trounce I, Polak MA, Koontz DA, Wallace DC: Maternally transmitted diabetes and deafness associated with a 10.4 kb mitochondrial DNA deletion. Nat Genet. 1992, 1: 11-15. 10.1038/ng0492-11. Taniguchi CM, Emanuelli B, Kahn CR: Critical nodes in signalling pathways: insights into insulin action. Nat Rev Mol Cell Biol. 2006, 7: 85-96. 10.1038/nrm1837. Kasuga M, Fujita-Yamaguchi Y, Blithe DL, Kahn CR: Tyrosine-specific protein kinase activity is associated with the purified insulin receptor. Proc Natl Acad Sci USA. 1983, 80: 2137-2141. 10.1073/pnas.80.8.2137. Thirone AC, Huang C, Klip A: Tissue-specific roles of IRS proteins in insulin signaling and glucose transport. Trends Endocrinol Metab. 2006, 17: 72-78. 10.1016/j.tem.2006.01.005. Backer JM, Myers MG, Shoelson SE, Chin DJ, Sun XJ, Miralpeix M, Hu P, Margolis B, Skolnik EY, Schlessinger J, et al.: Phosphatidylinositol 3'-kinase is activated by association with IRS-1 during insulin stimulation. EMBO J. 1992, 11: 3469-3479. Garami A, Zwartkruis FJ, Nobukuni T, Joaquin M, Roccio M, Stocker H, Kozma SC, Hafen E, Bos JL, Thomas G: Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2. Mol Cell. 2003, 11: 1457-1466. 10.1016/S1097-2765(03)00220-X. Desbois-Mouthon C, Cadoret A, Blivet-Van Eggelpoel MJ, Bertrand F, Cherqui G, Perret C, Capeau J: Insulin and IGF-1 stimulate the beta-catenin pathway through two signalling cascades involving GSK-3beta inhibition and Ras activation. Oncogene. 2001, 20: 252-259. 10.1038/sj.onc.1204064. Jefferson LS, Li JB, Rannels SR: Regulation by insulin of amino acid release and protein turnover in the perfused rat hemicorpus. J Biol Chem. 1977, 252: 1476-1483. Carel K, Kummer JL, Schubert C, Leitner W, Heidenreich KA, Draznin B: Insulin stimulates mitogen-activated protein kinase by a Ras-independent pathway in 3T3-L1 adipocytes. J Biol Chem. 1996, 271: 30625-30630. 10.1074/jbc.271.26.15311. Liang L, Jiang J, Frank SJ: Insulin receptor substrate-1-mediated enhancement of growth hormone-induced mitogen-activated protein kinase activation. Endocrinology. 2000, 141: 3328-3336. 10.1210/en.141.9.3328. Skolnik EY, Batzer A, Li N, Lee CH, Lowenstein E, Mohammadi M, Margolis B, Schlessinger J: The function of GRB2 in linking the insulin receptor to Ras signaling pathways. Science. 1993, 260: 1953-1955. 10.1126/science.8316835. Skolnik EY, Lee CH, Batzer A, Vicentini LM, Zhou M, Daly R, Myers MJ, Backer JM, Ullrich A, White MF, et al.: The SH2/SH3 domain-containing protein GRB2 interacts with tyrosine-phosphorylated IRS1 and Shc: implications for insulin control of ras signalling. EMBO J. 1993, 12: 1929-1936. MacDonald PE, Joseph JW, Rorsman P: Glucose-sensing mechanisms in pancreatic beta-cells. Philos Trans R Soc Lond B Biol Sci. 2005, 360: 2211-2225. 10.1098/rstb.2005.1762. Wiederkehr A, Wollheim CB: Minireview: implication of mitochondria in insulin secretion and action. Endocrinology. 2006, 147: 2643-2649. 10.1210/en.2006-0057. Biddinger SB, Kahn CR: From mice to men: insights into the insulin resistance syndromes. Annu Rev Physiol. 2006, 68: 123-158. 10.1146/annurev.physiol.68.040104.124723. Goodyear LJ, Giorgino F, Sherman LA, Carey J, Smith RJ, Dohm GL: Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects. J Clin Invest. 1995, 95: 2195-2204. 10.1172/JCI117909. Caro JF, Ittoop O, Pories WJ, Meelheim D, Flickinger EG, Thomas F, Jenquin M, Silverman JF, Khazanie PG, Sinha MK: Studies on the mechanism of insulin resistance in the liver from humans with noninsulin-dependent diabetes. Insulin action and binding in isolated hepatocytes, insulin receptor structure, and kinase activity. J Clin Invest. 1986, 78: 249-258. 10.1172/JCI112558. Tanti JF, Gremeaux T, van Obberghen E, Le Marchand-Brustel Y: Serine/threonine phosphorylation of insulin receptor substrate 1 modulates insulin receptor signaling. J Biol Chem. 1994, 269: 6051-6057. Lee YH, White MF: Insulin receptor substrate proteins and diabetes. Arch Pharm Res. 2004, 27: 361-370. Sun XJ, Goldberg JL, Qiao LY, Mitchell JJ: Insulin-induced insulin receptor substrate-1 degradation is mediated by the proteasome degradation pathway. Diabetes. 1999, 48: 1359-1364. 10.2337/diabetes.48.7.1359. Rui L, Fisher TL, Thomas J, White MF: Regulation of insulin/insulin-like growth factor-1 signaling by proteasome-mediated degradation of insulin receptor substrate-2. J Biol Chem. 2001, 276: 40362-40367. Rui L, Yuan M, Frantz D, Shoelson S, White MF: SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2. J Biol Chem. 2002, 277: 42394-42398. 10.1074/jbc.C200444200. Kamura T, Sato S, Haque D, Liu L, Kaelin WG, Conaway RC, Conaway JW: The Elongin BC complex interacts with the conserved SOCS-box motif present in members of the SOCS, ras, WD-40 repeat, and ankyrin repeat families. Genes Dev. 1998, 12: 3872-3881. 10.1101/gad.12.24.3872. Shoelson SE, Lee J, Goldfine AB: Inflammation and insulin resistance. J Clin Invest. 2006, 116: 1793-1801. 10.1172/JCI29069. Perreault M, Marette A: Targeted disruption of inducible nitric oxide synthase protects against obesity-linked insulin resistance in muscle. Nat Med. 2001, 7: 1138-1143. 10.1038/nm1001-1138. Sugita H, Fujimoto M, Yasukawa T, Shimizu N, Sugita M, Yasuhara S, Martyn JA, Kaneki M: Inducible nitric-oxide synthase and NO donor induce insulin receptor substrate-1 degradation in skeletal muscle cells. J Biol Chem. 2005, 280: 14203-14211. 10.1074/jbc.M411226200. Medina EA, Afsari RR, Ravid T, Castillo SS, Erickson KL, Goldkorn T: Tumor necrosis factor-{alpha} decreases Akt protein levels in 3T3-L1 adipocytes via the caspase-dependent ubiquitination of Akt. Endocrinology. 2005, 146: 2726-2735. 10.1210/en.2004-1074. Dentin R, Liu Y, Koo SH, Hedrick S, Vargas T, Heredia J, Yates J, Montminy M: Insulin modulates gluconeogenesis by inhibition of the coactivator TORC2. Nature. 2007, 449: 366-369. 10.1038/nature06128. Posner BI: Regulation of insulin receptor kinase activity by endosomal processes: possible areas for therapeutic intervention. Curr Opin Investig Drugs. 2003, 4: 430-434. Hicke L, Dunn R: Regulation of membrane protein transport by ubiquitin and ubiquitin-binding proteins. Annu Rev Cell Dev Biol. 2003, 19: 141-172. 10.1146/annurev.cellbio.19.110701.154617. Joazeiro CA, Wing SS, Huang H, Leverson JD, Hunter T, Liu YC: The Tyrosine Kinase Negative Regulator c-Cbl as a RING-Type, E2-Dependent Ubiquitin-Protein Ligase. Science. 1999, 286: 309-312. 10.1126/science.286.5438.309. Waterman H, Katz M, Rubin C, Shtiegman K, Lavi S, Elson A, Jovin T, Yarden Y: A mutant EGF-receptor defective in ubiquitylation and endocytosis unveils a role for Grb2 in negative signaling. Embo J. 2002, 21: 303-313. 10.1093/emboj/21.3.303. Peschard P, Fournier TM, Lamorte L, Naujokas MA, Band H, Langdon WY, Park M: Mutation of the c-Cbl TKB domain binding site on the Met receptor tyrosine kinase converts it into a transforming protein. Mol Cell. 2001, 8: 995-1004. 10.1016/S1097-2765(01)00378-1. Mori S, Claesson-Welsh L, Okuyama Y, Saito Y: Ligand-induced polyubiquitination of receptor tyrosine kinases. Biochem Biophys Res Commun. 1995, 213: 32-39. 10.1006/bbrc.1995.2094. PMID: 7639752 Vecchione A, Marchese A, Henry P, Rotin D, Morrione A: The Grb10/Nedd4 complex regulates ligand-induced ubiquitination and stability of the insulin-like growth factor I receptor. Mol Cell Biol. 2003, 23: 3363-3372. 10.1128/MCB.23.9.3363-3372.2003. Andoniou CE, Thien CB, Langdon WY: Tumour induction by activated abl involves tyrosine phosphorylation of the product of the cbl oncogene. Embo J. 1994, 13: 4515-4523. Peschard P, Park M: Escape from Cbl-mediated downregulation: a recurrent theme for oncogenic deregulation of receptor tyrosine kinases. Cancer Cell. 2003, 3: 519-523. 10.1016/S1535-6108(03)00136-3. Molero JC, Waring SG, Cooper A, Turner N, Laybutt R, Cooney GJ, James DE: Casitas b-lineage lymphoma-deficient mice are protected against high-fat diet-induced obesity and insulin resistance. Diabetes. 2006, 55: 708-715. 10.2337/diabetes.55.03.06.db05-0312. Lopez-Avalos MD, Duvivier-Kali VF, Xu G, Bonner-Weir S, Sharma A, Weir GC: Evidence for a role of the ubiquitin-proteasome pathway in pancreatic islets. Diabetes. 2006, 55: 1223-1231. 10.2337/db05-0450. Kawaguchi M, Minami K, Nagashima K, Seino S: Essential role of ubiquitin-proteasome system in normal regulation of insulin secretion. J Biol Chem. 2006, 281: 13015-13020. 10.1074/jbc.M601228200. Casas S, Gomis R, Gribble FM, Altirriba J, Knuutila S, Novials A: Impairment of the ubiquitin-proteasome pathway is a downstream endoplasmic reticulum stress response induced by extracellular human islet amyloid polypeptide and contributes to pancreatic beta-cell apoptosis. Diabetes. 2007, 56: 2284-2294. 10.2337/db07-0178. Kaniuk NA, Kiraly M, Bates H, Vranic M, Volchuk A, Brumell JH: Ubiquitinated-protein aggregates form in pancreatic beta-cells during diabetes-induced oxidative stress and are regulated by autophagy. Diabetes. 2007, 56: 930-939. 10.2337/db06-1160. Yan FF, Lin CW, Cartier EA, Shyng SL: Role of ubiquitin-proteasome degradation pathway in biogenesis efficiency of {beta}-cell ATP-sensitive potassium channels. Am J Physiol Cell Physiol. 2005, 289: C1351-1359. 10.1152/ajpcell.00240.2005. Briaud I, Dickson LM, Lingohr MK, McCuaig JF, Lawrence JC, Rhodes CJ: Insulin receptor substrate-2 proteasomal degradation mediated by a mammalian target of rapamycin (mTOR)-induced negative feedback down-regulates protein kinase B-mediated signaling pathway in beta-cells. J Biol Chem. 2005, 280: 2282-2293. 10.1074/jbc.M412179200. Liuwantara D, Elliot M, Smith MW, Yam AO, Walters SN, Marino E, McShea A, Grey ST: Nuclear factor-kappaB regulates beta-cell death: a critical role for A20 in beta-cell protection. Diabetes. 2006, 55: 2491-2501. 10.2337/db06-0142. Donaldson WE: Regulation of fatty acid synthesis. Fed Proc. 1979, 38: 2617-2621. PMID: 40828 Qi L, Heredia JE, Altarejos JY, Screaton R, Goebel N, Niessen S, Macleod IX, Liew CW, Kulkarni RN, Bain J, et al.: TRB3 links the E3 ubiquitin ligase COP1 to lipid metabolism. Science. 2006, 312: 1763-1766. 10.1126/science.1123374. Fisher EA, Zhou M, Mitchell DM, Wu X, Omura S, Wang H, Goldberg AL, Ginsberg HN: The degradation of apolipoprotein B100 is mediated by the ubiquitin-proteasome pathway and involves heat shock protein 70. J Biol Chem. 1997, 272: 20427-20434. 10.1074/jbc.272.33.20427. Levy E, Spahis S, Ziv E, Marette A, Elchebly M, Lambert M, Delvin E: Overproduction of intestinal lipoprotein containing apolipoprotein B-48 in Psammomys obesus: impact of dietary n-3 fatty acids. Diabetologia. 2006, 49: 1937-1945. 10.1007/s00125-006-0315-3. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J, Greenberg ME: Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell. 1999, 96: 857-868. 10.1016/S0092-8674(00)80595-4. Bodine SC, Latres E, Baumhueter S, Lai VK, Nunez L, Clarke BA, Poueymirou WT, Panaro FJ, Na E, Dharmarajan K, et al.: Identification of ubiquitin ligases required for skeletal muscle atrophy. Science. 2001, 294: 1704-1708. 10.1126/science.1065874. Khal J, Hine AV, Fearon KC, Dejong CH, Tisdale MJ: Increased expression of proteasome subunits in skeletal muscle of cancer patients with weight loss. Int J Biochem Cell Biol. 2005, 37: 2196-2206. 10.1016/j.biocel.2004.10.017. Leger B, Cartoni R, Praz M, Lamon S, Deriaz O, Crettenand A, Gobelet C, Rohmer P, Konzelmann M, Luthi F, Russell AP: Akt signalling through GSK-3beta, mTOR and Foxo1 is involved in human skeletal muscle hypertrophy and atrophy. J Physiol. 2006, 576: 923-933. 10.1113/jphysiol.2006.116715. Ogawa T, Furochi H, Mameoka M, Hirasaka K, Onishi Y, Suzue N, Oarada M, Akamatsu M, Akima H, Fukunaga T, et al.: Ubiquitin ligase gene expression in healthy volunteers with 20-day bedrest. Muscle Nerve. 2006, 34: 463-469. 10.1002/mus.20611. Tiao G, Hobler S, Wang JJ, Meyer TA, Luchette FA, Fischer JE, Hasselgren PO: Sepsis is associated with increased mRNAs of the ubiquitin-proteasome proteolytic pathway in human skeletal muscle. J Clin Invest. 1997, 99: 163-168. 10.1172/JCI119143. Rome S, Clement K, Rabasa-Lhoret R, Loizon E, Poitou C, Barsh GS, Riou JP, Laville M, Vidal H: Microarray profiling of human skeletal muscle reveals that insulin regulates approximately 800 genes during a hyperinsulinemic clamp. J Biol Chem. 2003, 278: 18063-18068. 10.1074/jbc.M300293200. Bennett RG, Fawcett J, Kruer MC, Duckworth WC, Hamel FG: Insulin inhibition of the proteasome is dependent on degradation of insulin by insulin-degrading enzyme. J Endocrinol. 2003, 177: 399-405. 10.1677/joe.0.1770399. Bohren KM, Nadkarni V, Song JH, Gabbay KH, Owerbach D: A M55V polymorphism in a novel SUMO gene (SUMO-4) differentially activates heat shock transcription factors and is associated with susceptibility to type I diabetes mellitus. J Biol Chem. 2004, 279: 27233-27238. 10.1074/jbc.M402273200. Li M, Guo D, Isales CM, Eizirik DL, Atkinson M, She JX, Wang CY: SUMO wrestling with type 1 diabetes. J Mol Med. 2005, 83: 504-513. 10.1007/s00109-005-0645-5. Leibel RL: Single gene obesities in rodents: possible relevance to human obesity. J Nutr. 1997, 127: 1908S- Phillips MS, Liu Q, Hammond HA, Dugan V, Hey PJ, Caskey CJ, Hess JF: Leptin receptor missense mutation in the fatty Zucker rat. Nat Genet. 1996, 13: 18-19. 10.1038/ng0596-18. Schreyer SA, Wilson DL, LeBoeuf RC: C57BL/6 mice fed high fat diets as models for diabetes-accelerated atherosclerosis. Atherosclerosis. 1998, 136: 17-24. 10.1016/S0021-9150(97)00165-2. Chen D, Wang MW: Development and application of rodent models for type 2 diabetes. Diabetes Obes Metab. 2005, 7: 307-317. 10.1111/j.1463-1326.2004.00392.x. Stegmeier F, Rape M, Draviam VM, Nalepa G, Sowa ME, Ang XL, McDonald ER, Li MZ, Hannon GJ, Sorger PK, et al.: Anaphase initiation is regulated by antagonistic ubiquitination and deubiquitination activities. Nature. 2007, 446: 876-881. 10.1038/nature05694. Xu X, Sarikas A, Dias-Santagata DC, Dolios G, Lafontant PJ, Tsai SC, Zhu W, Nakajima H, Nakajima HO, Field LJ, Wang R, Pan ZQ: The CUL7 E3 ubiquitin ligase targets insulin receptor substrate 1 for ubiquitin-dependent degradation. Mol Cell. 2008, 30 (4): 403-414. 10.1016/j.molcel.2008.03.009. Republished from Current BioData's Targeted Proteins database (TPdb; http://www.targetedproteinsdb.com).